The National Institutes of Health (NIH) has awarded funding to four regional medical center groups that will join a national network of healthcare provider organizations that will implement the Precision Medicine Initiative (PMI) cohort program.
The awardees include the California Precision Medicine Consortium, Danville, Pa.-based Geisinger Health System, the New England Precision Medicine Consortium and the Trans-American Consortium for the Health Care Systems Research Network.
Combined, the new healthcare provider organizations will receive initial funds of $5.5 million to begin recruitment and to build infrastructure. As efforts advance, the centers may receive first-year funds up to a total of $16 million, according to an NIH press release.
Beyond extending the program’s geographic reach, the new set of awardees have expertise in engaging racial and ethnic minority populations who have been historically underrepresented in biomedical research, according to the NIH. “The healthcare provider organizations are also well positioned to enroll over time populations that are often unable to take part in research, such as those with mental illnesses, substance abuse problems, developmental delays and cognitive impairments,” the NIH stated.
The four healthcare provider organizations join awardees announced earlier this year, to enroll interested individuals, gather participants’ health information and biospecimens and provide input on developing plans for the program.
The PMI Cohort Program is a landmark longitudinal research effort that aims to engage 1 million or more U.S. participants to enable research that will, over time, improve the ability to prevent and treat disease based on individual differences in lifestyle, environment and genetics. Participants will be invited to contribute a range of data about themselves by completing questionnaires, granting access to their electronic health records, providing blood and urine samples, undergoing a physical evaluation and sharing real-time information via smartphones or wearable devices. Data collected will be protected by privacy and security safeguards.
The California Precision Medicine Consortium consists of University of California San Diego, with partners Cedars-Sinai Medical Center, Los Angeles; San Diego Blood Bank; University of California, Davis; University of California Health; University of California, Irvine; University of California, San Francisco; and University of Southern California, Los Angeles.
The New England Precision Medicine Consortium consists of Partners HealthCare System and its hospitals, Massachusetts General Hospital and Brigham and Women’s Hospital, with Boston University and Boston Medical Center
And, the Trans-American Consortium for the Health Care Systems Research Network consists of Henry Ford Health System, Detroit, with partners Baylor Scott and White Research Institute, Dallas; Essentia Health, Duluth, Minnesota; Spectrum Health, Grand Rapids, Michigan; and University of Massachusetts Medical School, Worcester.
“These additional health care provider organizations will help us in our efforts to reach communities that have been underrepresented in research. By contributing their information, these communities will help people and their health care providers identify the right prevention strategies or treatments. With the PMI Cohort Program, we’re making a concerted effort to include people from all communities and walks of life, to make sure that the knowledge we gain benefits everyone,” Eric Dishman, director of the PMI Cohort Program, said in a statement.
Get the latest information on Population Health and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.